drugset / Trial / NCT00666939

A Study of Single-Dose Gabapentin in Subjects With Transient Insomnia Induced by a Sleep Phase Advance

NCT00666939

Phase 3 Completed 773 enrolled Viatris Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to assess the effect of gabapentin as compared to placebo on sleep, using subjective sleep measurements, in subjects with transient insomnia induced by a sleep phase advance.

Timeline

Start
2004-10
Primary completion
Completion
2005-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 100 mg Oral
Subject Gabapentin Small molecule 250 mg Oral

Indications